Astrazeneca reported $29.53B in Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
AstraZeneca AZN:LN 2425311.81M 57309.55M
Astrazeneca AZN:US $ 29528M 1571M
Bristol Myers Squibb BMY:US $ 42060M 2912M
Canopy Growth Corp WEED:CN C$ 1.46B 112.65M
Catalent CTLT:US $ 4202M 16M
Corcept Therapeutics CORT:US $ 0M 0M
Eli Lilly And LLY:US $ 16813.8M 305M
Endo International Ordinary Shares ENDP:US $ 8065.3M 25.32M
Genmab GEN:DC DK 634M 218M
GlaxoSmithKline GSK:LN 2211100M 1121700M
Horizon Pharma HZNP:US $ 2566.99M 1.75M
JAZZ PHA JAZZ:US $ 6021M 2.87M
Lannett LCI:US $ 614.95M 4.87M
Novartis NOVN:VX SF 31031M 244M
Pacira Pharmaceuticals PCRX:US $ 755.65M 167.77M
Perrigo Ordinary Shares PRGO:US $ 4116.9M 601.7M
Phibro Animal Health PAHC:US $ 417.92M 2.3M
Prestige Brands PBH:US $ 1479M 4.91M
Supernus Pharmaceuticals SUPN:US $ 400.91M 0.53M
Teva Pharmaceutical Industries TEVA:US $ 22082M 835M
Valeant Pharmaceuticals VRX:CN $ 28078.98M 4910.98M
Zoetis ZTS:US $ 6573M 5M